Skip to main content
. 2021 Aug 26;95:100642. doi: 10.1016/j.curtheres.2021.100642

Table 3.

Treatment (Tx) status (current and history) (N = 152).

Tx* First-line Tx Second-line Tx Third-line Tx Subsequent Tx
Current Tx at time of enrollment
 Radiation alone 2 (1.3) 1 (0.7)
 Systemic Tx alone 42 (27.6) 26 (17.1) 21 (13.8)
 Radiation and systemic 9 (5.9) 1 (0.7)
No current Tx
Tx received
 Surgery 3 (2.0) 4 (2.6)
 Radiation 6 (3.9) 5 (3.3) 1 (0.7)
 Systemic Tx 87 (57.2) 49 (32.2) 23 (15.1) 10 (6.6)
 Surgery + systemic Tx 3 (2.0)
 Radiation + systemic Tx 21 (13.8) 2 (1.3) 1 (0.7) 1 (0.7)
 Surgery + radiation + systemic Tx 3 (2.0)
 Not applicable 29 (19.1) 92 (60.5) 127 (83.6)
Those who received systemic Tx
 Received a platinum-based regimen 101 (66.4) 16 (10.5) 4 (2.6) 2 (1.3)
 Received a targeted therapy 35 (23.0) 31 (20.4) 13 (8.6) 5 (3.3)

Values are presented as n (%).

Fifty patients (32.9%) were not currently undergoing Tx.